Riskpilot← Back to searchSign inGet full accessPriodent Tibblekliniken AB
ABActiveOrg 5566348107Tibble Torg 1Dental practice care activities · NACE 8623Est. 20025-9 employees
Revenue 2025
SEK 15,3M
0% vs 2024
EBITDA margin
18.8%
-29% vs 2024
Equity ratio
18.4%
Financial strength
Net profit 2025
SEK 1,3M
-38% vs 2024
| Revenue | SEK 15,3M | +0% |
| EBITDA | SEK 2,9M | -29% |
| Net profit | SEK 1,3M | -38% |
| Total assets | SEK 7,9M | +12% |
| Equity | SEK 1,5M | -35% |
| Employees | — | — |
Legal name
Priodent Tibblekliniken AB
Org number
5566348107
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
20 november 2002
Share capital
SEK 100 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandvård samt därmed förenlig verksamhet.
Address
Tibble Torg 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11 587 | 17 220 | 14 240 | 15 292 | 15 318 |
| Staff expenses | — | — | — | −7 422 | −7 626 |
| EBITDA | 4 732 | 5 679 | 2 942 | 4 073 | 2 873 |
| Depreciation & amort. | −135 | −503 | −625 | −612 | −612 |
| EBIT | 4 597 | 5 176 | 2 317 | 3 461 | 2 260 |
| Net financials | — | −3 | 2 | 60 | 82 |
| Profit before tax | 3 496 | 3 823 | 1 673 | 2 685 | 1 670 |
| Tax | −751 | −798 | −345 | −589 | −371 |
| Net profit | 2 745 | 3 025 | 1 328 | 2 096 | 1 299 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 467 | 8 107 | 5 632 | 7 107 | 7 931 |
| Equity | 6 161 | 3 186 | 1 514 | 2 260 | 1 459 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 1 205 | 2 471 | 1 058 | 987 | 1 977 |
| Total debt | 1 205 | 2 471 | 1 058 | 987 | 1 977 |
EBITDA margin
18.8%
This company
15.8%
Market median
+19% vs market
20212025
Equity ratio
18.4%
This company
38.2%
Market median
-52% vs market
20212025
Return on equity
89.0%
This company
18.4%
Market median
+384% vs market
20212025
Net profit margin
8.5%
This company
8.1%
Market median
+5% vs market
20212025
Asset turnover
1.93×
This company
1.12×
Market median
+72% vs market
20212025
Debt / equity
4.44×
This company
0.62×
Market median
-616% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA Audit | Audit | 2022 |
| Former (1) | ||
AJ Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vatani Holding AB
Priodent Tibblekliniken AB Board members of Priodent Tibblekliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Axel Johannes Nelén | Audit | 0 companies |
| Philip Altinisik | Audit | 0 companies |
| Azadeh Hosseini Mirmahale | Deputy Board Member | 0 companies |
| Arash Vatani | Board of Directors | 0 companies |